title: MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
abstract: Glioma proliferation is a multistep process during which a sequence of genetic and epigenetic alterations randomly occur to affect the genes controlling cell proliferation, cell death and genetic stability. microRNAs are emerging as important epigenetic modulators of multiple target genes, leading to abnormal cellular signaling involving cellular proliferation in cancers.In the present study, we found that expression of miR-195 was markedly downregulated in glioma cell lines and human primary glioma tissues, compared to normal human astrocytes and matched non-tumor associated tissues. Upregulation of miR-195 dramatically reduced the proliferation of glioma cells. Flow cytometry analysis showed that ectopic expression of miR-195 significantly decreased the percentage of S phase cells and increased the percentage of G1/G0 phase cells. Overexpression of miR-195 dramatically reduced the anchorage-independent growth ability of glioma cells. Furthermore, overexpression of miR-195 downregulated the levels of phosphorylated retinoblastoma (pRb) and proliferating cell nuclear antigen (PCNA) in glioma cells. Conversely, inhibition of miR-195 promoted cell proliferation, increased the percentage of S phase cells, reduced the percentage of G1/G0 phase cells, enhanced anchorage-independent growth ability, upregulated the phosphorylation of pRb and PCNA in glioma cells. Moreover, we show that miR-195 inhibited glioma cell proliferation by downregulating expression of cyclin D1 and cyclin E1, via directly targeting the 3'-untranslated regions (3'-UTR) of cyclin D1 and cyclin E1 mRNA. Taken together, our results suggest that miR-195 plays an important role to inhibit the proliferation of glioma cells, and present a novel mechanism for direct miRNA-mediated suppression of cyclin D1 and cyclin E1 in glioma.
authors: Department of Neurosurgery, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
authors: Wang
authors: W
authors: Hui
authors: Lu
authors: L
authors: Yuntao
authors: Luo
authors: L
authors: Lun
authors: Li
authors: L
authors: WenSheng
authors: Liang
authors: L
authors: ChaoFeng
authors: He
authors: H
authors: HaiYong
authors: Ba
authors: B
authors: Yueyang
mesh_terms: D020413:3' Untranslated Regions / Q000235:genetics; D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000378:metabolism; D001483:Base Sequence; D014408:Biomarkers, Tumor / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D019938:Cyclin D1 / Q000235:genetics*; D019927:Cyclin E / Q000235:genetics*; D015536:Down-Regulation / Q000235:genetics; D005910:Glioma / Q000235:genetics / Q000473:pathology*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism*; D015513:Oncogene Proteins / Q000235:genetics*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism
chemical_list: D020413:3' Untranslated Regions; D014408:Biomarkers, Tumor; C475820:CCNE1 protein, human; D019927:Cyclin E; C552722:MIRN195 microRNA, human; D035683:MicroRNAs; D015513:Oncogene Proteins; D018809:Proliferating Cell Nuclear Antigen; D019938:Cyclin D1
references: Hum Pathol. 2006 Dec;37(12):1568-76
references: 16949911
references: Clin Exp Med. 2011 Jun;11(2):105-12
references: 20809334
references: Clin Cancer Res. 2008 Jun 1;14(11):3319-26
references: 18519759
references: Nat Rev Cancer. 2006 Apr;6(4):259-69
references: 16557279
references: Lung Cancer. 2007 Jan;55(1):1-14
references: 17070615
references: Cell. 1991 May 17;65(4):701-13
references: 1827757
references: Clin Cancer Res. 2009 Sep 15;15(18):5696-703
references: 19737942
references: Nature. 2004 Sep 16;431(7006):350-5
references: 15372042
references: Genes Dev. 2001 Jun 1;15(11):1311-33
references: 11390353
references: J Neurooncol. 2012 Feb;106(3):473-84
references: 21912938
references: Nature. 1998 Feb 5;391(6667):597-601
references: 9468139
references: Cell. 2008 Mar 7;132(5):860-74
references: 18329371
references: Clin Cancer Res. 2001 Aug;7(8):2387-95
references: 11489817
references: Ann Surg. 2010 Mar;251(3):499-505
references: 20134314
references: J Cell Physiol. 2011 Oct;226(10):2535-42
references: 21792910
references: Nature. 1998 Feb 5;391(6667):601-5
references: 9468140
references: J Gastroenterol Hepatol. 2009 Apr;24(4):652-7
references: 19175831
references: Cell Cycle. 2010 Dec 1;9(23):4638-49
references: 21084836
references: J Clin Oncol. 2006 Mar 10;24(8):1253-65
references: 16525180
references: Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S38-47
references: 14508079
references: Cell. 1991 Sep 20;66(6):1197-206
references: 1833066
references: J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):95-104
references: 15082921
references: Carcinogenesis. 2011 Jul;32(7):1025-32
references: 21551130
references: Mol Cell Biol. 1994 Mar;14(3):1669-79
references: 8114703
references: Science. 2006 Jan 6;311(5757):36-7
references: 16400132
references: Int J Cancer. 1996 Apr 22;69(2):92-9
references: 8608989
references: Annu Rev Pharmacol Toxicol. 1999;39:295-312
references: 10331086
references: J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93
references: 17971532
references: Nat Med. 2011 Nov 07;17(11):1359-70
references: 22064426
references: Cancer Res. 2005 May 1;65(9):3509-12
references: 15867338
references: Nature. 1999 Sep 16;401(6750):297-300
references: 10499591
references: Hepatology. 2009 Jul;50(1):113-21
references: 19441017
references: J Clin Oncol. 2005 Dec 20;23(36):9408-21
references: 16361640
references: PLoS One. 2012;7(2):e31450
references: 22319632
references: PLoS One. 2011 Jan 20;6(1):e16138
references: 21283765
references: Nature. 1998 Feb 5;391(6667):533, 535-6
references: 9468130
references: Endocrinology. 2004 Dec;145(12):5439-47
references: 15331580
references: Nat Rev Cancer. 2002 Aug;2(8):616-26
references: 12154354
references: Adv Cancer Res. 1996;68:67-108
references: 8712071
references: Nature. 1991 Apr 11;350(6318):512-5
references: 1826542
references: N Engl J Med. 2005 Aug 25;353(8):811-22
references: 16120861
references: Brain Res Brain Res Rev. 2004 Jul;45(3):143-63
references: 15210301
references: Neuro Oncol. 2012 Mar;14(3):278-87
references: 22217655
references: Cell. 2004 Jan 23;116(2):281-97
references: 14744438
references: Int J Cancer. 1999 Oct 29;83(3):387-92
references: 10495432
references: Nat Rev Cancer. 2006 Nov;6(11):857-66
references: 17060945
references: Cancer Res. 2008 Apr 15;68(8):2599-609
references: 18413728
references: N Engl J Med. 2005 Mar 10;352(10):987-96
references: 15758009
references: Nat Rev Genet. 2001 Feb;2(2):120-9
references: 11253051